BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mun SH, Park PSU, Park-Min KH. The M-CSF receptor in osteoclasts and beyond. Exp Mol Med 2020;52:1239-54. [PMID: 32801364 DOI: 10.1038/s12276-020-0484-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zinnia MA, Khademul Islam ABMM. Fenugreek steroidal saponins hinder osteoclastogenic bone resorption by targeting CSF-1R which diminishes the RANKL/OPG ratio. Int J Biol Macromol 2021;186:351-64. [PMID: 34217743 DOI: 10.1016/j.ijbiomac.2021.06.197] [Reference Citation Analysis]
2 Horikawa M, Kakiuchi Y, Kashima D, Ogawa K, Kawahara M. Thrombopoietin receptor-based protein-protein interaction screening (THROPPIS). Biotechnol Bioeng 2022;119:287-98. [PMID: 34708875 DOI: 10.1002/bit.27975] [Reference Citation Analysis]
3 Yang H, Wang L, Shigley C, Yang W. Protein tyrosine phosphatases in skeletal development and diseases. Bone Res 2022;10. [DOI: 10.1038/s41413-021-00181-x] [Reference Citation Analysis]
4 Mun SH, Bae S, Zeng S, Oh B, Chai C, Kim MJ, Kim H, Kalliolias G, Dahia CL, Oh Y, Kim TH, Ji JD, Park-Min KH. Augmenting MNK1/2 activation by c-FMS proteolysis promotes osteoclastogenesis and arthritic bone erosion. Bone Res 2021;9:45. [PMID: 34671034 DOI: 10.1038/s41413-021-00162-0] [Reference Citation Analysis]
5 Guo Y, Yuan Z, Liang Z, Wang Y, Wang Y, Xu L, Wei L. Maximal Information Coefficient-Based Testing to Identify Epistasis in Case-Control Association Studies. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/7843990] [Reference Citation Analysis]
6 Batoon L, McCauley LK. Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment. Front Endocrinol (Lausanne) 2021;12:763846. [PMID: 34803925 DOI: 10.3389/fendo.2021.763846] [Reference Citation Analysis]
7 Ordentlich P. Clinical evaluation of colony-stimulating factor 1 receptor inhibitors. Semin Immunol 2021;:101514. [PMID: 34776301 DOI: 10.1016/j.smim.2021.101514] [Reference Citation Analysis]
8 Sun Y, Li J, Xie X, Gu F, Sui Z, Zhang K, Yu T. Recent Advances in Osteoclast Biological Behavior. Front Cell Dev Biol 2021;9:788680. [PMID: 34957116 DOI: 10.3389/fcell.2021.788680] [Reference Citation Analysis]
9 Wu YZ, Huang HT, Cheng TL, Lu YM, Lin SY, Ho CJ, Lee TC, Hsu CH, Huang PJ, Huang HH, Li JY, Su YD, Chen SC, Kang L, Chen CH. Application of microRNA in Human Osteoporosis and Fragility Fracture: A Systemic Review of Literatures. Int J Mol Sci 2021;22:5232. [PMID: 34063380 DOI: 10.3390/ijms22105232] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Kanegasaki S, Tsuchiya T. A possible way to prevent the progression of bone lesions in multiple myeloma via Src-homology-region-2-domain-containing-phosphatase-1 activation. J Cell Biochem 2021. [PMID: 33969922 DOI: 10.1002/jcb.29949] [Reference Citation Analysis]
11 Park PSU, Raynor WY, Sun Y, Werner TJ, Rajapakse CS, Alavi A. 18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications. Int J Mol Sci 2021;22:6504. [PMID: 34204387 DOI: 10.3390/ijms22126504] [Reference Citation Analysis]
12 Huang JM, Wang CZ, Lu SY, Wang Z, Yan ZQ. Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity. Drug Des Devel Ther 2021;15:4811-25. [PMID: 34876805 DOI: 10.2147/DDDT.S328238] [Reference Citation Analysis]
13 Guo L, Ikegawa S. From HDLS to BANDDOS: fast-expanding phenotypic spectrum of disorders caused by mutations in CSF1R. J Hum Genet 2021. [PMID: 34135456 DOI: 10.1038/s10038-021-00942-w] [Reference Citation Analysis]
14 Ekeuku SO, Pang KL, Chin KY. The Skeletal Effects of Tanshinones: A Review. Molecules 2021;26:2319. [PMID: 33923673 DOI: 10.3390/molecules26082319] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Soto-Diaz K, Vailati-Riboni M, Louie AY, McKim DB, Gaskins HR, Johnson RW, Steelman AJ. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species. Front Immunol 2021;12:734349. [PMID: 34899694 DOI: 10.3389/fimmu.2021.734349] [Reference Citation Analysis]
16 Ching K, Houard X, Berenbaum F, Wen C. Hypertension meets osteoarthritis - revisiting the vascular aetiology hypothesis. Nat Rev Rheumatol 2021;17:533-49. [PMID: 34316066 DOI: 10.1038/s41584-021-00650-x] [Reference Citation Analysis]
17 Li Y, Luo Y, Li X, Huang Z, Wang Y. Nanoparticles breakthroughs tumor treatment limitations by regulating tumor immune microenvironment to enhance tumor immunotherapy efficacy. Smart Materials in Medicine 2021;2:314-21. [DOI: 10.1016/j.smaim.2021.08.004] [Reference Citation Analysis]
18 Liu Z, Yin Y, Wang Z, Xie L, Deng P, Wang D, Ji N, Zhao H, Han X, Chen Q, Chung CH, Bai D, Zhao X. RANKL inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia. Bone 2021;156:116301. [PMID: 34952228 DOI: 10.1016/j.bone.2021.116301] [Reference Citation Analysis]
19 Tang CC, Castro Andrade CD, O'Meara MJ, Yoon SH, Sato T, Brooks DJ, Bouxsein ML, Martins JDS, Wang J, Gray NS, Misof B, Roschger P, Blouin S, Klaushofer K, Velduis-Vlug A, Vegting Y, Rosen CJ, O'Connell D, Sundberg TB, Xavier RJ, Ung P, Schlessinger A, Kronenberg HM, Berdeaux R, Foretz M, Wein MN. Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption. Elife 2021;10:e67772. [PMID: 34160349 DOI: 10.7554/eLife.67772] [Reference Citation Analysis]
20 Terkawi MA, Matsumae G, Shimizu T, Takahashi D, Kadoya K, Iwasaki N. Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives. Int J Mol Sci 2022;23:1786. [PMID: 35163708 DOI: 10.3390/ijms23031786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Sharma G, Pothuraju R, Kanchan RK, Batra SK, Siddiqui JA. Chemokines network in bone metastasis: Vital regulators of seeding and soiling. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.02.003] [Reference Citation Analysis]
22 Lyadova I, Gerasimova T, Nenasheva T. Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions. Front Cell Dev Biol 2021;9:640703. [PMID: 34150747 DOI: 10.3389/fcell.2021.640703] [Reference Citation Analysis]
23 Mun SH, Oh B, Lee MJ, Bae S, Yang Y, Park-min K. THOC5 regulates human osteoclastogenesis. European Journal of Cell Biology 2022;101:151248. [DOI: 10.1016/j.ejcb.2022.151248] [Reference Citation Analysis]
24 Okada H, Tanaka S. Plasmalemmal interface for calcium signaling in osteoclast differentiation. Current Opinion in Cell Biology 2022;74:55-61. [DOI: 10.1016/j.ceb.2022.01.001] [Reference Citation Analysis]